Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
Main Authors: | Clarke Atkins, Bruce Keene, Teresa C. DeFrancesco, Sandra Tou, Valérie Chetboul, Étienne Côté, Stephen Ettinger, Philip R. Fox, Robert L. Hamlin, Jonathan P. Mochel, Jean‐Louis Pouchelon, Rebecca L. Stepien |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Journal of Veterinary Internal Medicine |
Online Access: | https://doi.org/10.1111/jvim.16035 |
Similar Items
-
Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
by: Mark A. Oyama, et al.
Published: (2021-03-01) -
Response to letter to editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
by: Gerhard Wess, et al.
Published: (2021-03-01) -
Response to letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
by: Gerhard Wess, et al.
Published: (2021-03-01) -
Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs
by: Prapawadee Pirintr, et al.
Published: (2023-10-01) -
Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
by: Anna K. McManamey, et al.
Published: (2023-11-01)